Merck delays filing for combo cholesterol drug
298628
Merck & Co.MRK.N said on Friday it   has delayed filing for a high-profile combination pill designed   to lower "bad" cholesterol and increase "good" cholesterol,   while heading off a common side effect of one of the   ingredients.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
149716
German drug maker Altana said that it had postponed its application for approval of its new asthma treatment Roflumilast in the United States in order to undertake additional clinical trials on the drug.
672526
Merck & Co. MRK.N said on Friday it   would delay seeking approval for a combination pill designed to   lower "bad" cholesterol, increase "good" cholesterol and avoid   a common side effect of one of the ingredients.
339141
Merck can&#39;t expect any immediate relief from the medicine that was supposed to replace Vioxx, the pain medication it took off the market.
578766
The company announces another slight delay with its lead drug.
472584
NEW YORK - In a capstone to the withdrawal of Vioxx, the US Food and Drug Administration has decided to delay the approval of successor drug Arcoxia until more safety data are available.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
207329
Merck & Co's combination pill to raise "good" HDL cholesterol with less facial flushing -- a common side effect of HDL drugs -- met its main goals in a late-stage test, researchers said on Sunday.
514713
BETHESDA, Md.  - U.S. advisers are set to decide  on Friday whether they will recommend approval for Merck & Co.  Inc.'s plan to sell a cholesterol-lowering medicine on  drugstore shelves without a prescription.
407294
The biotech company announces new drug delays.
379753
Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and aims to have another four products in late-stage trials by midyear, the company said on Tuesday.
208932
GlaxoSmithKline Plc's cervical cancer vaccine Cervarix faces a delay in winning approval in the United States, putting it further behind Merck & Co Inc's rival product Gardasil.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.
759985
The government is questioning if too many of the wrong people will take cholesterol-lowering Mevacor if it's sold without a prescription, days before Merck & Co. makes its third try to move the drug over the counter.
606459
Genentech said that approval of its colon cancer drug Avastin as a treatment for breast cancer would be delayed by at least a year.
721591
Merck &amp; Co., Inc., knew of problems with its blockbuster painkiller Vioxx long before the drug was pulled from the market in September due to newer studies that linked the medication to an increased risk of heart attack and stroke, the Wall Street Journal